| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 05/18/2006 | US20060104950 Methods of Tranducing genes into T cells |
| 05/18/2006 | DE19608751B4 Verwendung eines Adeno-assoziierten Virus-Vektors zur Steigerung der Immunogenität von Zellen Using an adeno-associated virus vector to enhance the immunogenicity of cells |
| 05/18/2006 | CA2587469A1 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 05/18/2006 | CA2587451A1 Defective influenza virus particles |
| 05/18/2006 | CA2584815A1 Stable and filterable enveloped virus formulations |
| 05/17/2006 | EP1657309A1 Viral production process |
| 05/17/2006 | EP1222300B1 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 05/17/2006 | EP0788372B1 Attenuated canine parvovirus vaccine |
| 05/17/2006 | CN1774264A Recombinant herpesvirus of turkeys and use thereof |
| 05/17/2006 | CN1772909A Reverse genetic operation system of New castle disease LaSota vaccine strain and its applciation |
| 05/17/2006 | CN1772892A HIV-1 virus-like particle and its prepn and use |
| 05/17/2006 | CN1772887A Recombinant Newcastle disease LaSota low virulent vaccine strain expressing bird flu virus H5 subtype HA protein |
| 05/17/2006 | CN1772886A Recombinant Newcastle disease LaSota low virulent vaccine strain expressing infectious bursal disease virus VP2 gene |
| 05/16/2006 | US7045685 Insect viruses and their uses in protecting plants |
| 05/16/2006 | US7045598 Recombinant infectious laryngotracheitis virus and uses thereof |
| 05/16/2006 | US7045536 Compound having anti-viral activity |
| 05/16/2006 | US7045347 Helper dependent adenovirus vectors based on integrase family site-specific recombinases |
| 05/16/2006 | US7045335 Immunotherapy; genetic engineering; anticancer agents |
| 05/11/2006 | WO2006050193A2 Bacteriophages as selective agents |
| 05/11/2006 | WO2006048228A1 Method for the generation of virus producing cell lines and cell lines |
| 05/11/2006 | WO2005082929A3 Beak and feather disease virus sequences, compositions and vaccines and the use thereof in therapy, diagnosis and assays |
| 05/11/2006 | WO2002094997A3 Transcriptional regulation of target genes |
| 05/11/2006 | US20060099606 Assay to detect viral uncoating |
| 05/11/2006 | US20060099595 Culturing an Huh-7.5 cell line (ATCC accession number PTA-8561) that also has a genomic or subgenomic HCV RNA capable of replication, curing with an antiviral agent, and identifying sublines that are permissive for HCV replication. |
| 05/11/2006 | US20060099587 Alphavirus vectors having attentuated virion structural proteins |
| 05/11/2006 | US20060099226 Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
| 05/11/2006 | US20060099224 Methods and compositions concerning poxviruses and cancer |
| 05/11/2006 | US20060099184 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions vectors |
| 05/11/2006 | US20060099181 Viral vectors having reduced virulence |
| 05/11/2006 | US20060099178 Novel use of adenoviruses and nucleic acids coding therefor |
| 05/10/2006 | EP1654390A2 Liquid crystal based analyte detection |
| 05/10/2006 | EP1185297B1 Streptococcus pneumoniae proteins and vaccines |
| 05/10/2006 | EP0988389B1 Method for the production of non-group c adenoviral vectors |
| 05/10/2006 | EP0809700B1 Papilloma virus-like particles, fusion proteins and process for producing the same |
| 05/10/2006 | CN1769435A Porcine circus-virus 2 type recombinant adenovirus and vaccine |
| 05/10/2006 | CN1769434A Porcine circus-virus 2 type recombinant adenovirus and its construction method and uses |
| 05/10/2006 | CN1769433A Recombinant vesicular stomatitis virus and its uses |
| 05/10/2006 | CN1255550C Recovery of enzyme activity from enveloped viruses |
| 05/10/2006 | CN1255540C Vaccine-induced hepatitis B viral strain and uses thereof |
| 05/10/2006 | CN1255539C Pesticidal proteins and strains |
| 05/09/2006 | US7041813 Canine herpes virus alpha transinducing factor nucleic acid molecules |
| 05/09/2006 | US7041500 Insect cell line |
| 05/09/2006 | US7041489 Vaccines |
| 05/09/2006 | US7041444 Murine calicivirus |
| 05/09/2006 | US7041443 For therapy of porcine subject at risk of infection by, or displaying symptoms of, a porcine reproductive and respiratory syndrome virus infection |
| 05/09/2006 | US7041300 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines |
| 05/09/2006 | US7041299 vaccine against Newcastle Disease contains one or more mutant immunogens of the NDW strain that lack the antigenic binding site on the F glycoprotein which is recognized by the monoclonal antibody mAb 54. |
| 05/04/2006 | WO2006046963A2 Generation of virus-like particles and use as panfilovirus vaccine |
| 05/04/2006 | WO2006046943A2 Methods for producing lipids by liberation from biomass |
| 05/04/2006 | WO2006045532A2 Virosome particles comprising antigens from influenza virus and hepatitis b virus |
| 05/04/2006 | WO2006045438A1 Animal protein-free media for cultivation of cells |
| 05/04/2006 | WO2005101966A3 Lipid-extracted therapeutic vaccine and method of use |
| 05/04/2006 | WO2004037972A3 Endogenous retrovirus up-regulated in prostate cancer |
| 05/04/2006 | US20060094116 High-efficiency wild-type-free AAV helper functions |
| 05/04/2006 | US20060094105 Mixed cell diagnostic systems for detection of respiratory, herpes and enteric viruses |
| 05/04/2006 | US20060094104 Nutrient broth comprising polyamines and plant and/or yeast-derived hydrolysate for propagation of transgenic/infected cells |
| 05/04/2006 | US20060094076 Bacteriophages as selective agents |
| 05/04/2006 | US20060094049 Stabilized viral envelope proteins and uses thereof |
| 05/04/2006 | US20060094030 Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics |
| 05/04/2006 | US20060093585 Providing mammalian cell contacted with agent and adeno-associated virus (AAV), identifying agent that when contacted with mammalian cell enhances AAV transduction after viral binding to membrane of contacted mammalian cell and before second strand synthesis which yields expressible form of viral genome |
| 05/04/2006 | CA2585518A1 Animal protein-free media for cultivation of cells |
| 05/03/2006 | EP1652932A1 Method for the generation of virus producing cell lines and cell lines |
| 05/03/2006 | EP1652931A2 Recombinant adenoviruses, preparation and uses thereof for the treatment and/or prevention ofs cancers |
| 05/03/2006 | EP1652919A1 Improvements to ribosome display |
| 05/03/2006 | EP1652914A1 Virosome particles comprising antigens from influenza virus and Hepatitis B virus |
| 05/03/2006 | EP1651666A1 Alphavirus-based cytomegalovirus vaccines |
| 05/03/2006 | EP0702717B1 Generation, concentration and efficient transfer of vsv-g pseudotyped retroviral vectors |
| 05/03/2006 | CN1768078A Antibodies directed against hepatitis c virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions |
| 05/03/2006 | CN1254543C Method |
| 05/02/2006 | US7038035 Nucleic acids codes polypeptides; mutants; insertion a vector; culturing; recovering |
| 05/02/2006 | US7037723 Highly infectious virus vector; forming expression cassettes; insertion into herpes virus genome; replication |
| 05/02/2006 | US7037718 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof |
| 05/02/2006 | US7037716 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 05/02/2006 | US7037713 Nucleotide sequences coding viral proteins for use as tools in genetic engineering and gene therapy |
| 05/02/2006 | US7037707 Mammalian cell culture; gene replacement; genetic engineering |
| 05/02/2006 | US7037706 Compounds displayed on replicable genetic packages and methods of using same |
| 05/02/2006 | US7037648 Somatic transfer of modified genes to predict drug effects |
| 05/02/2006 | US7037642 Removing compounds from blood products with porous particles immobilized in a matrix |
| 05/02/2006 | US7037509 Immunologically significant herpes simplex virus antigens and methods for using same |
| 05/02/2006 | US7037508 Pestivirus mutants and vaccines containing the same |
| 04/27/2006 | WO2006042414A1 Improved viral purification methods |
| 04/27/2006 | WO2005092918A3 Targeting polypeptide |
| 04/27/2006 | WO2005040349A3 Immunogenic composition and method of developing a vaccine based on cyclophilin a binding site |
| 04/27/2006 | US20060088937 Flavivirus expression and delivery system |
| 04/27/2006 | US20060088909 Virus-like particles, methods of preparation, and immunogenic compositions |
| 04/27/2006 | US20060088820 Detecting superantigen activity in a biological sample |
| 04/27/2006 | US20060088550 Gastric inhibitory polypeptide (GIP) antigen arrays and uses thereof |
| 04/27/2006 | US20060088549 Chimeric virus vaccine |
| 04/27/2006 | US20060088536 Therapeutic drug using antibody-presenting hollow protein nanoparticles and hollow protein nanoparticles |
| 04/27/2006 | DE19741739B4 Supramolekulares Paarungssystem, dessen Herstellung und Verwendung Supramolecular mating system, its preparation and use |
| 04/26/2006 | EP1650310A1 Recombinant avian adenovirus vector |
| 04/26/2006 | EP1650309A1 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 04/26/2006 | EP1649053A2 Characterization of the earliest stages of the severe acute respiratory syndrome (sars) virus and uses thereof |
| 04/26/2006 | EP1649020A1 Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof |
| 04/26/2006 | EP1649011A2 Novel keratinocyte culturing method and the use thereof |
| 04/26/2006 | EP1648481A1 Viral vectors |
| 04/26/2006 | EP1648233A2 Mutants of vaccinia virus as oncolytic agents |
| 04/26/2006 | EP1474533B1 Method of determining adenovirus particle concentration |
| 04/26/2006 | EP1474521B1 An herpes simplex virus complex |
| 04/26/2006 | EP1105466B1 Process for purifying human papillomavirus virus-like particles |